Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep725 | Pituitary and Neuroendocrinology | ECE2023

Coexistence of PRL-secreting adenoma and germ cell tumor in 14-year-old adolescent

Kalinin Alexey , Strebkova Natalia , Chugunov Igor , Kolesnikova Galina , Bezlepkina Olga , Zheludkova Olga , Peterkova Valentina

Coexistence of different types of brain tumors is a very rare condition. We present a clinical case of PRL-secreting adenoma and germ cell tumor coexistence in 14-year-old adolescent. The patient was admitted to our Center with complaints of headache with nausea episodes, left-sided ptosis. Visual acuity was: visus OD=1.0; visus OS=0.6 Cyl -0.5 ax 70=1.0. Neuroimaging revealed supra-para(D,S) sellar mass 39×32×21 mm. Laboratory data revealed hypothyroidism, hypocorti...

ea0035p187 | Cardiovascular Endocrinology & Lipid Metabolism | ECE2014

Metabolic outcomes in childhood cancer survivors

Tselovalnikova Tatiana , Pavlova Maria , Zilov Alexey , Mazerkina Nadezhda , Zheludkova Olga

Aim: The aim of this study was to evaluate metabolic abnormalities in young adults getting treatments of acute lymphoblastic leukemia (ALL) and brain tumors (BT) in their childhood.Methods: We examined 50 patients in two groups. The group-1: 18 ALL-survivors (nine women and nine men). All of them received cranial irradiation in dose up to 18 Gy and chemotherapy. In group-2: 32 BT-survivors (14 women and 18 men) were included. All patients received cranio...

ea0034p183 | Neoplasia, cancer and late effects | SFEBES2014

Long-term negative effects in young cancer survivors: metabolic disorders in the patients after complex treatment for brain tumors and acute lymphoblastic leukemia in childhood and adolescence

Tselovalnikova Tatiana , Pavlova Maria , Zilov Alexey , Mazerkina Nadezhda , Zheludkova Olga

Aim: The aim of this study was to examine the incidence of metabolic abnormalities in adults getting treatments of brain tumors (BT) and acute lymphoblastic leukemia (ALL) in their childhood or adolescence.Methods: patients were divided in two groups. In group 1: 31 BT survivors (13 women and 18 men) were included. All patients received craniospinal irradiation up to 36 Gy and boost to the tumor up to 55 Gy and chemotherapy. The group 2: 18 ALL survivors...

ea0056p862 | Pituitary - Clinical | ECE2018

Growth hormone secretion in children treated for medulloblastoma

Kalinin Alexey , Strebkova Natalia , Zheludkova Olga , Kareva Maria

Medulloblastoma is the most common malignant brain tumor in childhood. Treatment of medulloblastoma includes surgery, radiation therapy and chemotherapy. Craniospinal radiation can cause adverse effects on the endocrine system, specifically on the hypothalamic-pituitary axis. Increasing survival rates of pediatric patients with brain tumors lead to increased concern regarding long-term quality of life, including the detection and correction of endocrine disorders. One of the m...

ea0063p1051 | Pituitary and Neuroendocrinology 3 | ECE2019

A comparison of glucagon stimulation and insulin tolerance test in young adults followed craniospinal irradiation

Yudina Alla , Pavlova Maria , Sotnikov Vladimir , Mazerkina Nadezhda , Zheludkova Olga , Martynova Evgeniya

The glucagon stimulation test (GST) may be used as a good alternative to the insulin tolerance test (ITT) in the diagnosis of secondary adrenal insufficiency (SAI). The aim of the study was to compare the GST and ITT for diagnostic SAI, to define cortisol cut-off points and factors affecting the appearance of false positive results in young adults followed CSI.Subjects and Methods: A retrospective study of 28 patients (median age 19 [17; 23]) at least 2 ...

ea0063p1080 | Pituitary and Neuroendocrinology 3 | ECE2019

Impairment of glucose tolerance in children and adolescentstreated for medulloblastoma

Natalia Strebkova , Kalinin Alexey , Vasyukova Olga , Okorokov Pavel , Kareva Maria , Zheludkova Olga

Children and adolescents treated for solid brain tumors with chemotherapy and craniospinal irradiation are at increased risk of metabolic changes development. Current follow-up guidelines for cancer survivors recommend to monitor fasting glucose and HbA1 levels for diabetes/impaired glucose tolerance screening in these patients. The aim of our study was to evaluate metabolic changes in children treated for medulloblastoma with oral glucose tolerance test (OGTT). We examined 63...